Navigation Links
Prasco Announces New, Expanded Roles for Key Executives
Date:12/6/2011

CINCINNATI, Dec. 6, 2011 /PRNewswire/ -- Prasco Chairman, Mr. E. Thomas Arington, announced today that Mr. Christopher H. Arington has been promoted to vice chairman and chief executive officer of Prasco.  He also announced the promotion of Mr. David Vucurevich, R.Ph. to president, chief operating officer, Mr. David Furniss as chief financial officer, and Mr. Chris Gilmore vice president, strategic business ventures.

"I am extremely pleased to announce these management changes," said E. Thomas Arington.  "As one of the founders of Prasco, Chris has played a critical role in the development and evolution of the company from day-to-day operations to the larger strategic picture," Arington said.  "Mr. Vucurevich brings extensive experience in the pharmaceutical industry, as well as a 'get it done' management style and a commitment to excellence, which is so appropriate for Prasco at this point in time. As CFO, Mr. David Furniss brings financial acumen and over twenty years of pharmaceutical industry experience.  Mr. Furniss, along with Mr. Chris Gilmore, a former Prasco Authorized Generics Business executive, will play key roles in developing and implementing new business opportunities, including acquisitions," Arington concluded.

"It is an honor to accept the position as Prasco CEO and to join Mr. David Vucurevich, in leading Prasco forward," said Chris Arington, CEO.  "I am extremely pleased with Prasco's existing leadership team and we look forward to expanding Prasco's role in the pharmaceutical industry."

About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution.  For more information, visit www.prasco.com.


'/>"/>
SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
2. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
3. Prasco® Launches Authorized Generic with Shionogi Inc.
4. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
5. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
6. Prasco to Market Authorized Generic of ZEGERID®
7. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
8. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
9. CPhI Conferences Announces Details of 5th Annual PharmaSource Conference in Munich
10. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
11. AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... April 29, 2017 , ... ... company, today announced the launch of DonorBridge, its process and engagement analytics ... of software innovation and industry expertise with predictive analytics to help nonprofits ...
(Date:4/29/2017)... ... ... More than half of Americans suffering from noise-induced hearing loss do not ... causes hearing loss? May 1 marks the beginning of Better Hearing & Speech Month—a ... as schedule a hearing evaluation for anyone with concerns about his/her hearing. , Approximately ...
(Date:4/28/2017)... ... April 28, 2017 , ... It's not always common knowledge ... of illnesses that are unclear as to whether or not they are contagious, and ... one of these illnesses. So, FindaTopDoc took a look into the matter. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced ... test throughout the Northeast U.S. , GlycoMark is the only clinically available ... test provides a clinically proven one- to two-week measure of hyperglycemic excursions, often ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children ... to more adverse experiences than children in the general population. That’s because foster ... neglect or other family challenges. While no fault of their own, youth who ...
Breaking Medicine News(10 mins):